|
|
|
|
|
Kardium's Globe System Begins First-in-BC Clinical Trial at St. Paul's Hospital
|
Burnaby, BC, April 14, 2022--Kardium Inc. announces a successful first-in-BC investigational* clinical procedure using the Globe Mapping and Ablation System. Dr. Marc Deyell of St. Paul's Hospital leads the study using the Globe System to navigate inside the heart and diagnose where the rhythm disturbances occur. Once identified, the same device can then deliver immediate treatment to restore the normal heart rhythm and confirm successful treatment.
|
|
|
|
|
|
Kardium Performs First Cases with the Globe® Positioning System
|
Vancouver, BC, November 17, 2020--Kardium announced the first clinical use of the Globe Positioning System (GPS™) - the new 3D mapping and navigation feature of its flagship product, the Globe® Mapping and Ablation System. The Globe System is a complete solution for the treatment of atrial fibrillation (AF) - the world's most common heart rhythm disorder.
|
|
|
|
|
|
Kardium Receives CE mark for Globe® Mapping and Ablation System
|
Vancouver, BC, June 30, 2020--Kardium Inc. announced that it has received CE mark approval for its Globe Mapping and Ablation System - the most complete solution for the treatment of atrial fibrillation (AF). AF is the world's most common heart rhythm disorder, affecting more than 37 million people. This approval allows Kardium to begin commercial sales of the Globe System in Europe.
|
|
|
|